BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37115627)

  • 1. Beneficial effects of exercise initiated before development of hypertrophic cardiomyopathy in genotype-positive mice.
    Andreassen K; Rixon C; Hansen MH; Hauge-Iversen IM; Zhang L; Sadredini M; Erusappan PM; Sjaastad I; Christensen G; Haugaa KH; Edvardsen T; Lunde IG; Stokke MK
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H881-H892. PubMed ID: 37115627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy.
    Rixon C; Andreassen K; Shen X; Erusappan PM; Almaas VM; Palmero S; Dahl CP; Ueland T; Sjaastad I; Louch WE; Stokke MK; Tønnessen T; Christensen G; Lunde IG
    ESC Heart Fail; 2023 Apr; 10(2):858-871. PubMed ID: 36444917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
    J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigorous exercise in patients with hypertrophic cardiomyopathy.
    Dejgaard LA; Haland TF; Lie OH; Ribe M; Bjune T; Leren IS; Berge KE; Edvardsen T; Haugaa KH
    Int J Cardiol; 2018 Jan; 250():157-163. PubMed ID: 29169752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
    Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
    J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
    JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
    Andreassen K; Dejgaard LA; Lie Ø; Fink TS; Lunde IG; Edvardsen T; Haugaa KH; Stokke MK
    Int J Cardiol; 2022 Oct; 364():65-71. PubMed ID: 35714718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
    Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
    Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Strain and Function in Pediatric Hypertrophic Cardiomyopathy.
    Jhaveri S; Komarlu R; Worley S; Shahbah D; Gurumoorthi M; Zahka K
    J Am Soc Echocardiogr; 2021 Sep; 34(9):996-1006. PubMed ID: 33915246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
    Konhilas JP; Watson PA; Maass A; Boucek DM; Horn T; Stauffer BL; Luckey SW; Rosenberg P; Leinwand LA
    Circ Res; 2006 Mar; 98(4):540-8. PubMed ID: 16439687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy.
    Khalilimeybodi A; Saucerman JJ; Rangamani P
    Comput Biol Med; 2024 Jun; 175():108499. PubMed ID: 38677172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
    Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy.
    Geske JB; Bos JM; Gersh BJ; Ommen SR; Eidem BW; Ackerman MJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):456-65. PubMed ID: 24217980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.
    Shah AB; Bechis MZ; Brown M; Finch JM; Loomer G; Groezinger E; Weiner RB; Wasfy MM; Picard MH; Fifer MA; Lewis GB; Baggish AL
    J Physiol; 2019 Mar; 597(5):1337-1346. PubMed ID: 30552684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.
    Lampert R; Ackerman MJ; Marino BS; Burg M; Ainsworth B; Salberg L; Tome Esteban MT; Ho CY; Abraham R; Balaji S; Barth C; Berul CI; Bos M; Cannom D; Choudhury L; Concannon M; Cooper R; Czosek RJ; Dubin AM; Dziura J; Eidem B; Emery MS; Estes NAM; Etheridge SP; Geske JB; Gray B; Hall K; Harmon KG; James CA; Lal AK; Law IH; Li F; Link MS; McKenna WJ; Molossi S; Olshansky B; Ommen SR; Saarel EV; Saberi S; Simone L; Tomaselli G; Ware JS; Zipes DP; Day SM;
    JAMA Cardiol; 2023 Jun; 8(6):595-605. PubMed ID: 37195701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.